NCT00401635View on ClinicalTrials.gov

END-1: First Line Chemotherapy for Advanced or Recurrent Endometrial Carcinoma With Carboplatin and Liposomal Doxorubicin

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2002

Conditions

Endometrial Cancer

Interventions

DRUG

liposomal doxorubicin

DRUG

carboplatin

Trial Locations (4)

47100

Ospedale Pierantoni, Divisione di Oncologia Medica, Forlì

80131

Istituto Nazionale dei Tumori , Divisione di Oncologia Medica B, Napoli

82100

Ospedale Fatebenefratelli, U.O. di Oncologia, Benevento

00186

Ospedale S. Giovanni Calibita Fatebenefratelli, Roma

All Listed Sponsors

lead

National Cancer Institute, Naples

OTHER

NCT00401635 - END-1: First Line Chemotherapy for Advanced or Recurrent Endometrial Carcinoma With Carboplatin and Liposomal Doxorubicin | Biotech Hunter | Biotech Hunter